Surgical Site Infections (SSI)^5,6 
‐ 37% of hospital acquired infections in surgical patients are SSIs 
‐ Patients with an SSI are twice as likely to spend time in an intensive care unit 
‐ Patients with an SSI are five times more likely to be readmitted after discharge 
‐ Patients with an SSI are twice as likely to die 
‐ 40‐60% of surgical site infections may be preventable  

SSIs are common & costly for patients and hospitals; the average cost of managing a single patient with an SSI was estimated at £3,122.^7-9*

Multiple meta-analyses support the use of PLUS Antibacterial Sutures to reduce the risk of SSI by up to 28%.^10-12

In the presence of a foreign body, such as suture, it takes only 100 staphylococci per gram of tissue for an SSI to develop¹³

Once a suture is introduced into a surgical incision, bacteria on the surface of the epidermis, disrupted while making a skin incision, migrate from the surface to the foreign body, which is the site of SSI initiation.^14,15

Plus Antibacterial Sutures have been shown in vitro to inhibit bacterial colonization of the suture for 7 days or more and are effective against the most common organisms associated with SSIs: ^4,16,17
-Staphylococcus aureus
-Staphylococcus epidermidis
-MRSA
-MRSE
-Escherichia coli**
-K pneumoniae**